PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly

INTRODUCTION: Real-world data evaluating patients’ injection experiences using the latest devices/formulations of the long-acting (LA) somatostatin analogs (SSAs) lanreotide Autogel/Depot (LAN; Somatuline®) and octreotide LA release (OCT; Sandostatin®) are limited. METHODS: PRESTO 2 was a 2020/2021...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Toole, Dermot, Kunz, Pamela L., Webb, Susan M., Goldstein, Grace, Khawaja, Sheila, McDonnell, Mark, Boiziau, Sandra, Gueguen, Delphine, Houchard, Aude, Ribeiro-Oliveira, Antonio, Prebtani, Ally
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741754/
https://www.ncbi.nlm.nih.gov/pubmed/36502449
http://dx.doi.org/10.1007/s12325-022-02360-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741754/
https://www.ncbi.nlm.nih.gov/pubmed/36502449
http://dx.doi.org/10.1007/s12325-022-02360-6

Ejemplares similares